Sept 1 (Reuters) - XTD Ltd (XTD) FY revenue from continuing operations $2.9 million versus $3.5 million FY loss for the year attributable to owners $2.2 million versus loss of $2.5 million
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025